Characteristic | Lidocaine/Naproxen | Lidocaine/Placebo | Saline/Naproxen | Saline/Placebo | P |
---|---|---|---|---|---|
Physician pain assessment | 0.77 ± 0.11 | 0.56 ± 0.09 | 0.48 ± 0.11 | 0.59 ± 0.8 | 0.238 |
Visual analog pain score | 3.38 ± 2.49 | 2.87 ± 2.13 | 3.09 ± 2.18 | 3.62 ± 2.45 | 0.456 |
Post procedure analgesia | 0.568 | ||||
Yes | 10 (25) | 8 (20) | 9 (22.5) | 12 (30.8) | |
No | 28 (70) | 28 (70) | 31 (77.5) | 22 (56.4) | |
Satisfaction with procedure | 4.36 ± 0.84 | 4.26 ± 0.94 | 4.3 ± 0.94 | 4.4 ± 0.9 | 0.910 |
Satisfaction with IUD (Day 30) | 0.701 | ||||
Levonorgestrel 52 mg | 4.40 ± 0.75 | 4.36 ± 0.97 | 4.35 ± 1.1 | 4.38 ± 0.89 | |
Copper T380A | 4.31 ± 0.95 | 4.16 ± 0.92 | 4.3 ± 0.81 | 4.47 ± 0.94 | |
Physician pain assessment | 0.31 | ||||
Levonorgestrel 52 mg | 0.90 ± 0.72 | 0.50 ± 0.11 | 0.55 ± 0.18 | 0.53 ± 0.12 | |
Copper T380A | 0.63 ± 0.13 | 0.63 ± 0.14 | 0.40 ± 0.11 | 0.63 ± 0.11 | |
Visual analog pain score | |||||
Levonorgestrel 52 mg | 3.55 ± 0.55 | 2.45 ± 0.44 | 2.85 ± 0.45 | 3.26 ± 0.54 | 0.09 |
Copper T380A | 3.26 ± 0.59 | 3.32 ± 0.52 | 3.35 ± 0.52 | 4.00 ± 0.58 | |
Post procedure analgesia | |||||
Levonorgestrel 52 mg | 0.65 | ||||
Yes | 3 (16) [0.33] | 3 (17) [0.23] | 5 (25) [0.09] | 5 (31) [0.64] | |
No | 16 (84) [0.09] | 15 (83) [0.06] | 15 (75) [0.02] | 11 (69) [0.18] | |
Copper T380A | 0.43 | ||||
Yes | 7 (41) [0.45] | 5 (28) [0.10] | 4 (20) [0.89] | 7 (41) [0.45] | |
No | 10 (59) [0.21] | 13 (72) [0.05] | 16 (80) [0.42] | 10 (59) [0.21] |